Women with endometriosis, those freezing eggs for social reasons, and transgender individuals face unique ethical hurdles when saving their fertility. A review of 56 scientific articles shows these patients often struggle with decisional pressure and a lack of proper information. This makes it hard for them to make truly future-oriented choices about their bodies. The analysis highlights that safeguarding genetic parenthood is seen as a major benefit, yet it comes with significant risks. Patients might face delays in necessary therapy, receive misinformation, or develop false hope about their future reproductive options. These issues create a complex picture where the desire to preserve fertility clashes with the need for honest, safe medical care. The review also points out that unequal access to care and gender discrimination remain serious problems. Many people simply cannot afford these procedures or lack health insurance coverage. Because the ethics of these non-cancer cases are explored less than cancer treatments, the field needs a tailored approach. Doctors and patients must work together to ensure that everyone gets fair treatment and clear information. The goal is to support reproductive autonomy without leaving anyone behind or exposing them to unnecessary harm.
Ethical analysis of non-oncological fertility preservation reviews challenges in reproductive autonomy and social justiceFertility preservation ethics face real risks for women and transgender people
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This narrative review examines 56 scientific articles to explore the ethics of non-oncological fertility preservation. The scope includes women with endometriosis, women opting for social egg freezing, and transgender individuals. The analysis contrasts these cases with oncological fertility preservation to highlight specific ethical dimensions.
The authors synthesize findings on reproductive autonomy, noting challenges such as decisional pressure, provision of proper information, and questionable ability to make future-oriented decisions. Regarding beneficence, the review discusses notions of medical, psychological, social, and personal benefit, most notably the benefits of safeguarding genetic parenthood and prevention of future regret.
On non-maleficence, the analysis identifies medical, psychological, and social risks, such as delay in therapy, misinformation, and false hope. Social justice concerns include problems like unequal access, lack of health insurance coverage, and gender discrimination. The authors note that the ethics of non-oncological cases remains less explored.
The review supports the need for a tailored ethical approach to these patients. Practice relevance is limited by the lack of reported sample sizes, effect sizes, or p-values, as this is an ethical analysis rather than a primary clinical trial.